Journal articles on the topic 'Peptidomimetic inhibitors'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Peptidomimetic inhibitors.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Kikelj, Danijel. "Peptidomimetic Thrombin Inhibitors." Pathophysiology of Haemostasis and Thrombosis 33, no. 5-6 (2003): 487–91. http://dx.doi.org/10.1159/000083850.
Full textDong, Guangping, Iredia D. Iyamu, Jonah Z. Vilseck, Dongxing Chen, and Rong Huang. "Improved Cell-Potent and Selective Peptidomimetic Inhibitors of Protein N-Terminal Methyltransferase 1." Molecules 27, no. 4 (February 18, 2022): 1381. http://dx.doi.org/10.3390/molecules27041381.
Full textTurkson, James, Joon S. Kim, Shumin Zhang, Jing Yuan, Mei Huang, Matthew Glenn, Eric Haura, Said Sebti, Andrew D. Hamilton, and Richard Jove. "Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity." Molecular Cancer Therapeutics 3, no. 3 (March 1, 2004): 261–69. http://dx.doi.org/10.1158/1535-7163.261.3.3.
Full textRandolph, John, and David DeGoey. "Peptidomimetic Inhibitors of HIV Protease." Current Topics in Medicinal Chemistry 4, no. 10 (June 1, 2004): 1079–95. http://dx.doi.org/10.2174/1568026043388330.
Full textCameron Black, W. "Peptidomimetic Inhibitors of Cathepsin K." Current Topics in Medicinal Chemistry 10, no. 7 (May 1, 2010): 745–51. http://dx.doi.org/10.2174/156802610791113450.
Full textMarsters, James C., Robert S. McDowell, Mark E. Reynolds, David A. Oare, Todd C. Somers, Mark S. Stanley, Thomas E. Rawson, et al. "Benzodiazepine peptidomimetic inhibitors of farnesyltransferase." Bioorganic & Medicinal Chemistry 2, no. 9 (September 1994): 949–57. http://dx.doi.org/10.1016/s0968-0896(00)82044-1.
Full textMarsters, James C., Robert S. McDowelll, Mark E. Reynolds, Todd C. Somers, Joseph L. Goldstein, Michael S. Brown, and Guy L. James. "Peptidomimetic inhibitors of Ras farnesylation." Chemistry & Biology 1 (April 1994): viii—ix. http://dx.doi.org/10.1016/1074-5521(94)90021-3.
Full textSantos, André L. S., Filipe P. Matteoli, Leandro S. Sangenito, Marta H. Branquinha, Bruno A. Cotrim, and Gabriel O. Resende. "Asymmetric peptidomimetics containing L-tartaric acid core inhibit the aspartyl peptidase activity and growth of Leishmania amazonensis promastigotes." Acta Parasitologica 63, no. 1 (March 26, 2018): 114–24. http://dx.doi.org/10.1515/ap-2018-0013.
Full textBarbotte, Laetitia, Abdelhakim Ahmed-Belkacem, Stéphane Chevaliez, Alexandre Soulier, Christophe Hézode, Henri Wajcman, Doug J. Bartels, et al. "Characterization of V36C, a Novel Amino Acid Substitution Conferring Hepatitis C Virus (HCV) Resistance to Telaprevir, a Potent Peptidomimetic Inhibitor of HCV Protease." Antimicrobial Agents and Chemotherapy 54, no. 6 (April 5, 2010): 2681–83. http://dx.doi.org/10.1128/aac.01796-09.
Full textKinena, Linda, Gundars Leitis, Iveta Kanepe-Lapsa, Raitis Bobrovs, Kristaps Jaudzems, Vita Ozola, Edgars Suna, and Aigars Jirgensons. "Azole-based non-peptidomimetic plasmepsin inhibitors." Archiv der Pharmazie 351, no. 9 (July 31, 2018): 1800151. http://dx.doi.org/10.1002/ardp.201800151.
Full textKinena, Linda, and Vita Ozola. "Tetrahydroisoquinoline-Based Non-Peptidomimetic Plasmepsin Inhibitors." Chemistry of Heterocyclic Compounds 56, no. 1 (January 2020): 60–66. http://dx.doi.org/10.1007/s10593-020-02623-6.
Full textEast, Stephen P., Andrew Ayscough, Ian Toogood-Johnson, Steven Taylor, and Wayne Thomas. "Peptidomimetic inhibitors of bacterial peptide deformylase." Bioorganic & Medicinal Chemistry Letters 21, no. 13 (July 2011): 4032–35. http://dx.doi.org/10.1016/j.bmcl.2011.04.132.
Full textFrecer, Vladimir, and Stanislav Miertus. "Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease." RSC Advances 10, no. 66 (2020): 40244–63. http://dx.doi.org/10.1039/d0ra08304f.
Full textMartins, Lucas Sousa, Hendrik Gerhardus Kruger, Tricia Naicker, Cláudio Nahum Alves, Jerônimo Lameira, and José Rogério Araújo Silva. "Computational insights for predicting the binding and selectivity of peptidomimetic plasmepsin IV inhibitors against cathepsin D." RSC Advances 13, no. 1 (2023): 602–14. http://dx.doi.org/10.1039/d2ra06246a.
Full textSawyer, Tomi, Regine Bohacek, David Dalgarno, Charles Eyermann, Noriyuki Kawahata, Chester Metcalf III, William Shakespeare, Raji Sundaramoorthi, Yihan Wang, and Michael Yang. "Src Homology-2 Inhibitors: Peptidomimetic and Nonpeptide." Mini-Reviews in Medicinal Chemistry 2, no. 5 (October 1, 2002): 475–88. http://dx.doi.org/10.2174/1389557023405765.
Full textPang, X., Z. Liu, and G. Zhai. "Advances in Non-peptidomimetic HIV Protease Inhibitors." Current Medicinal Chemistry 21, no. 17 (April 2014): 1997–2011. http://dx.doi.org/10.2174/0929867321666140217115951.
Full textZimmerman, Craig N. "Peptide and peptidomimetic inhibitors of VLA-4." Expert Opinion on Therapeutic Patents 9, no. 2 (February 1999): 129–33. http://dx.doi.org/10.1517/13543776.9.2.129.
Full textOgilvie, William, Murray Bailey, Marc-André Poupart, Abraham, Amit Bhavsar, Pierre Bonneau, Josée Bordeleau, et al. "Peptidomimetic Inhibitors of the Human Cytomegalovirus Protease." Journal of Medicinal Chemistry 40, no. 25 (December 1997): 4113–35. http://dx.doi.org/10.1021/jm970104t.
Full textYin, Hang, Kendra K. Frederick, Dahui Liu, A. Joshua Wand, and William F. DeGrado. "Arylamide Derivatives as Peptidomimetic Inhibitors of Calmodulin." Organic Letters 8, no. 2 (January 2006): 223–25. http://dx.doi.org/10.1021/ol052478j.
Full textShen, Kui, Lixin Qi, and Lynn Stiff. "Peptidomimetic Competitive Inhibitors of Protein Tyrosine Phosphatases." Current Pharmaceutical Design 16, no. 28 (September 1, 2010): 3101–17. http://dx.doi.org/10.2174/138161210793292537.
Full textMicale, Nicola, Roberta Ettari, Antonio Lavecchia, Carmen Di Giovanni, Kety Scarbaci, Valeria Troiano, Silvana Grasso, Ettore Novellino, Tanja Schirmeister, and Maria Zappalà. "Development of peptidomimetic boronates as proteasome inhibitors." European Journal of Medicinal Chemistry 64 (June 2013): 23–34. http://dx.doi.org/10.1016/j.ejmech.2013.03.032.
Full textButini, Stefania, Emanuele Gabellieri, Margherita Brindisi, Simone Giovani, Samuele Maramai, Giridhar Kshirsagar, Egeria Guarino, et al. "A stereoselective approach to peptidomimetic BACE1 inhibitors." European Journal of Medicinal Chemistry 70 (December 2013): 233–47. http://dx.doi.org/10.1016/j.ejmech.2013.09.056.
Full textMajer, Filip, Libuše Pavlíčková, Pavel Majer, Martin Hradilek, Elena Dolejší, Olga Hrušková-Heidingsfeldová, and Iva Pichová. "Structure-based specificity mapping of secreted aspartic proteases of Candida parapsilosis, Candida albicans, and Candida tropicalis using peptidomimetic inhibitors and homology modeling." Biological Chemistry 387, no. 9 (September 1, 2006): 1247–54. http://dx.doi.org/10.1515/bc.2006.154.
Full textDoro, Fabio, Cinzia Colombo, Chiara Alberti, Daniela Arosio, Laura Belvisi, Cesare Casagrande, Roberto Fanelli, et al. "Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions." Organic & Biomolecular Chemistry 13, no. 9 (2015): 2570–73. http://dx.doi.org/10.1039/c4ob02538e.
Full textSanders, Alyssa, Samuel Ricci, Sarah Uribe, Bridget Boyle, Brian Nepper, and Nathaniel Nucci. "A Survey of Inhibitors for the Main Protease of Coronaviruses with the Potential for Development of Broad-Spectrum Therapeutics." American Journal of Undergraduate Research 17, no. 4 (March 31, 2021): 71–84. http://dx.doi.org/10.33697/ajur.2020.037.
Full textBrožková, Kateřina, Ivana Křížová, Libuše Pavlíčková, Martin Hradilek, Martin Fusek, Tomáš Ruml, Milan Souček, and Iva Pichová. "Peptidomimetic Inhibitors of Extracellular Aspartic Proteinases of Candida albicans and Candida tropicalis." Collection of Czechoslovak Chemical Communications 64, no. 1 (1999): 130–37. http://dx.doi.org/10.1135/cccc19990130.
Full textMasłowska, Katarzyna, Ewa Witkowska, Dagmara Tymecka, Paweł Krzysztof Halik, Aleksandra Misicka, and Ewa Gniazdowska. "Synthesis, Physicochemical and Biological Study of Gallium-68- and Lutetium-177-Labeled VEGF-A165/NRP-1 Complex Inhibitors Based on Peptide A7R and Branched Peptidomimetic." Pharmaceutics 14, no. 1 (January 1, 2022): 100. http://dx.doi.org/10.3390/pharmaceutics14010100.
Full textKarlsson, Christoffer, Magnus Blom, Miranda Johansson (neé Varedian), Anna M. Jansson, Enzo Scifo, Anders Karlén, Thavendran Govender, and Adolf Gogoll. "Phototriggerable peptidomimetics for the inhibition of Mycobacterium tuberculosis ribonucleotide reductase by targeting protein–protein binding." Organic & Biomolecular Chemistry 13, no. 9 (2015): 2612–21. http://dx.doi.org/10.1039/c4ob01926a.
Full textAbdel-Rahman, Hamdy, Gamal Al-karamany, Nawal El-Koussi, Adel Youssef, and Yoshiaki Kiso. "HIV Protease Inhibitors: Peptidomimetic Drugs and Future Perspectives." Current Medicinal Chemistry 9, no. 21 (November 1, 2002): 1905–22. http://dx.doi.org/10.2174/0929867023368890.
Full textQiu, X., and Z. P. Liu. "Recent Developments of Peptidomimetic HIV-1 Protease Inhibitors." Current Medicinal Chemistry 18, no. 29 (October 1, 2011): 4513–37. http://dx.doi.org/10.2174/092986711797287566.
Full textIbrahim, Medhat, Noha A. Saleh, Wael M. Elshemey, and Anwar A. Elsayed. "QSAR Properties of Novel Peptidomimetic NS3 Protease Inhibitors." Journal of Computational and Theoretical Nanoscience 10, no. 4 (April 1, 2013): 785–88. http://dx.doi.org/10.1166/jctn.2013.2771.
Full textChun, Jiong, Ye Ingrid Yin, Guangli Yang, Leonid Tarassishin, and Yue-Ming Li. "Stereoselective Synthesis of Photoreactive Peptidomimetic γ-Secretase Inhibitors." Journal of Organic Chemistry 69, no. 21 (October 2004): 7344–47. http://dx.doi.org/10.1021/jo0486948.
Full textVan der Veken, Pieter, Kristel Senten, István Kertèsz, Ingrid De Meester, Anne-Marie Lambeir, Marie-Berthe Maes, Simon Scharpé, Achiel Haemers, and Koen Augustyns. "Fluoro-Olefins as Peptidomimetic Inhibitors of Dipeptidyl Peptidases." Journal of Medicinal Chemistry 48, no. 6 (March 2005): 1768–80. http://dx.doi.org/10.1021/jm0495982.
Full textShiraishi, Takuya, Shojiro Kadono, Masayuki Haramura, Hirofumi Kodama, Yoshiyuki Ono, Hitoshi Iikura, Tohru Esaki, et al. "Design and Synthesis of Peptidomimetic Factor VIIa Inhibitors." CHEMICAL & PHARMACEUTICAL BULLETIN 58, no. 1 (2010): 38–44. http://dx.doi.org/10.1248/cpb.58.38.
Full textOlaleye, Tayo O., James A. Brannigan, Shirley M. Roberts, Robin J. Leatherbarrow, Anthony J. Wilkinson, and Edward W. Tate. "Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites." Org. Biomol. Chem. 12, no. 41 (2014): 8132–37. http://dx.doi.org/10.1039/c4ob01669f.
Full textHammoudan, Imad, Soumaya Matchi, Mohamed Bakhouch, Salah Belaidi, and Samir Chtita. "QSAR Modelling of Peptidomimetic Derivatives towards HKU4-CoV 3CLpro Inhibitors against MERS-CoV." Chemistry 3, no. 1 (March 9, 2021): 391–401. http://dx.doi.org/10.3390/chemistry3010029.
Full textDamalanka, Vishnu C., Scott A. Wildman, and James W. Janetka. "Piperidine carbamate peptidomimetic inhibitors of the serine proteases HGFA, matriptase and hepsin." MedChemComm 10, no. 9 (2019): 1646–55. http://dx.doi.org/10.1039/c9md00234k.
Full textBekono, Boris D., Akori E. Esmel, Brice Dali, Fidele Ntie-Kang, Melalie Keita, Luc C. O. Owono, and Eugene Megnassan. "Computer-Aided Design of Peptidomimetic Inhibitors of Falcipain-3: QSAR and Pharmacophore Models." Scientia Pharmaceutica 89, no. 4 (September 29, 2021): 44. http://dx.doi.org/10.3390/scipharm89040044.
Full textKlei, Herbert E., Kevin Kish, Pin-Fang M. Lin, Qi Guo, Jacques Friborg, Ronald E. Rose, Yaqun Zhang, et al. "X-Ray Crystal Structures of Human Immunodeficiency Virus Type 1 Protease Mutants Complexed with Atazanavir." Journal of Virology 81, no. 17 (May 30, 2007): 9525–35. http://dx.doi.org/10.1128/jvi.02503-05.
Full textPandit, Rakesh K. R., Dinesh Gupta, and Tapan K. Mukherjee. "IDENTIFICATION OF POTENTIAL SALMONELLA TYPHI BETA-LACTAMASE TEM 1 INHIBITORS USING PEPTIDOMIMETICS, VIRTUAL SCREENING, AND MOLECULAR DYNAMICS SIMULATIONS." International Journal of Pharmacy and Pharmaceutical Sciences 10, no. 1 (January 1, 2018): 91. http://dx.doi.org/10.22159/ijpps.2018v10i1.21520.
Full textYadav, Mange R., Anil K. Shinde, Bishram S. Chouhan, Rajani Giridhar, and Robert Menard. "Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors." Journal of Enzyme Inhibition and Medicinal Chemistry 23, no. 2 (January 1, 2008): 190–97. http://dx.doi.org/10.1080/14756360701504842.
Full textMicale, Nicola, Alan P. Kozikowski, Roberta Ettari, Silvana Grasso, Maria Zappalà, Jong-Jin Jeong, Ajay Kumar, Manjit Hanspal, and Athar H. Chishti. "Novel Peptidomimetic Cysteine Protease Inhibitors as Potential Antimalarial Agents." Journal of Medicinal Chemistry 49, no. 11 (June 2006): 3064–67. http://dx.doi.org/10.1021/jm060405f.
Full textFear, Georgie, Slavko Komarnytsky, and Ilya Raskin. "Protease inhibitors and their peptidomimetic derivatives as potential drugs." Pharmacology & Therapeutics 113, no. 2 (February 2007): 354–68. http://dx.doi.org/10.1016/j.pharmthera.2006.09.001.
Full textBurg, Danny, Dmitri V. Filippov, Ralph Hermanns, Gijs A. van der Marel, Jacques H. van Boom, and Gerard J. Mulder. "Peptidomimetic Glutathione Analogues as Novel γGT Stable GST Inhibitors." Bioorganic & Medicinal Chemistry 10, no. 1 (January 2002): 195–205. http://dx.doi.org/10.1016/s0968-0896(01)00269-3.
Full textOhkanda, Junko, Jeffrey W. Lockman, Kohei Yokoyama, Michael H. Gelb, Simon L. Croft, Howard Kendrick, Maria Isabel Harrell, et al. "Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity." Bioorganic & Medicinal Chemistry Letters 11, no. 6 (March 2001): 761–64. http://dx.doi.org/10.1016/s0960-894x(01)00055-5.
Full textSanders, M. Lee, and Isaac O. Donkor. "A novel series of urea-based peptidomimetic calpain inhibitors." Bioorganic & Medicinal Chemistry Letters 16, no. 7 (April 2006): 1965–68. http://dx.doi.org/10.1016/j.bmcl.2005.12.068.
Full textChenna, Bala C., Linfeng Li, Drake M. Mellott, Xiang Zhai, Jair L. Siqueira-Neto, Claudia Calvet Alvarez, Jean A. Bernatchez, et al. "Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity." Journal of Medicinal Chemistry 63, no. 6 (March 3, 2020): 3298–316. http://dx.doi.org/10.1021/acs.jmedchem.9b02078.
Full textGokhale, Kunal M., and Vikas N. Telvekar. "Novel peptidomimetic peptide deformylase (PDF) inhibitors of Mycobacterium tuberculosis." Chemical Biology & Drug Design 97, no. 1 (August 24, 2020): 148–56. http://dx.doi.org/10.1111/cbdd.13769.
Full textHatahet, Feras, and Lloyd Ruddock. "Modulating Proteostasis: Peptidomimetic Inhibitors and Activators of Protein Folding." Current Pharmaceutical Design 15, no. 21 (July 1, 2009): 2488–507. http://dx.doi.org/10.2174/138161209788682343.
Full textCalugi, Chiara, Andrea Trabocchi, Claudia Lalli, and Antonio Guarna. "d-Proline-based peptidomimetic inhibitors of anthrax lethal factor." European Journal of Medicinal Chemistry 56 (October 2012): 96–107. http://dx.doi.org/10.1016/j.ejmech.2012.08.028.
Full text